Aquestive Therapeutics AQST paid Bracewell $60K for lobbying in Q1 2026 · Consumer Issues, Health Issues

Trade details

Type: Lobbying report
Amount: $60,000
Quarter: Q1 2026
Stock: Aquestive Therapeutics AQST
Client: Aquestive Therapeutics
Reported: 26/04/17

Up 0.0% from last quarter

What else happened in Aquestive Therapeutics around then

Filed or reported within 30 days of the trade day · 03/01~04/30

Aquestive Therapeutics's other lobbying reports

Aquestive Therapeutics
LobbyingAquestive Therapeutics
Lobbying
Aquestive Therapeutics
AQST
$60K
$60K
Reported 07/16
for Q2
Aquestive Therapeutics
LobbyingAquestive Therapeutics
Lobbying
Aquestive Therapeutics
AQST
$60K
$60K
Reported 01/20
for Q4 2025
Aquestive Therapeutics
LobbyingAquestive Therapeutics
Lobbying
Aquestive Therapeutics
AQST
$50K
$50K
Reported 25/10/20
for Q3 2025
Aquestive Therapeutics
LobbyingAquestive Therapeutics
Lobbying
Aquestive Therapeutics
AQST
$30K
$30K
Reported 25/07/21
for Q2 2025
Aquestive Therapeutics
LobbyingAquestive Therapeutics
Lobbying
Aquestive Therapeutics
AQST
$20K
$20K
Reported 25/04/21
for Q1 2025

Aquestive Therapeutics AQST paid Bracewell $60K for lobbying in Q1 2026 · Consumer Issues, Health Issues | Whalegun